钆贝葡胺增强肝胆期胆道成像对肝细胞癌患者肝切除术后肝衰竭的预测价值
在两中心接受钆贝葡胺增强肝胆期MRI的221例肝细胞癌患者中,27.1%发生肝切除术后肝衰竭。胆道系统相对强化率(REB)是术后肝衰竭的独立危险因素(OR=0.127),其预测AUC为0.87,最佳截断值为2.21;REB≤2.21者术后肝衰竭发生率显著高于REB>2.21者(60.0% vs 8.5%)。
要点
- 肝胆期胆道系统相对强化率(REB)是肝细胞癌患者肝切除术后肝衰竭的独立危险因素。
- REB预测术后肝衰竭的AUC为0.87,最佳截断值为2.21。
- REB≤2.21者术后肝衰竭发生率60.0%,显著高于REB>2.21者的8.5%。
核心结论
- 钆贝葡胺增强肝胆期胆道成像对预测肝细胞癌患者肝切除术后肝衰竭有价值。
研究设计与样本
- 两中心收集肝细胞癌患者,术前接受钆贝葡胺增强肝胆期MRI,共221例,分析REB与肝-肌比值(LMR)对术后肝衰竭的预测能力。
诊断标准与关键数值
- REB预测术后肝衰竭的AUC为0.87,最佳截断值为2.21;LMR的AUC为0.60;REB≤2.21者术后肝衰竭发生率60.0%,REB>2.21者为8.5%(p<0.001)。
临床应用与阅片要点
- 肝胆期可测量胆道系统相对强化率(REB),REB≤2.21提示术后肝衰竭风险较高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC).
METHODS: Patients with HCC who underwent gadobenate dimeglumine-enhanced hepatobiliary magnetic resonance imaging prior to hepatectomy were collected in two centers. The relative enhancement ratio of the biliary system (REB) and the liver to muscle ratio (LMR) were measured at the hepatobiliary phase. Potential risk factors for PHLF were analyzed by logistic regression. The capacity of the REB and LMR to predict PHLF was analyzed via receiver operating characteristic curve.
RESULTS: Of the 221 patients, post-hepatectomy liver failure occurred in 60 patients (27.1%). The REB was an independent risk factor for PHLF (odds ratio [OR] = 0.127 [0.047-0.348], p < 0.001). Although the LMR tended to be associated with PHLF (p = 0.063), it was not an independent risk factor in the multivariable analysis (OR = 0.624 [0.023-16.709], p = 0.779). Moreover, the area under the receiver operating characteristic curve of the REB and LMR was 0.87 and 0.60. The most appropriate cutoff value for the REB was 2.21. The HCC patients with the REB ≤ 2.21 had a higher incidence of post-hepatectomy liver failure than those with the REB > 2.21 (60.0% versus 8.5%, p < 0.001).
CONCLUSIONS: Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase was valuable in predicting post-hepatectomy liver failure in HCC patients.
KEY POINTS: • The relative enhancement ratio of the biliary system (REB) was an independent risk factor for post-hepatectomy liver failure in HCC patients. • HCC patients with the REB ≤ 2.21 had significantly higher incidence of post-hepatectomy liver failure than those with the REB > 2.21 (60.0% versus 8.5%).
引用
- Meng D, Liang C, Zheng Y, et al. The value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients. Eur Radiol. 2022. PMID: 35639146. doi:10.1007/s00330-022-08874-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。